Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Optimal indications for second-line chemotherapy in advanced gastric cancer

(2012) Hiroko Hasegawa et al.   ANTI-CANCER DRUGS

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

(2012) Jung Hun Kang et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chemotherapy in the Treatment of Metastatic Gastric Cancer: Is There a Global Standard?

(2011) Hyunseok Kang et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer

(2011) Hyun Jeong Shim et al.   Gastric Cancer

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

(2011) Eun Kyoung Jeon et al.   Cancer Research and Treatment

A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer

(2010) Byung Geun Kim et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

A Phase II Study of Irinotecan, Continuous 5-Fluorouracil, and Leucovorin (FOLFIRI) Combination Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer Previously Treated With a Fluoropyrimidine-Based Regimen

(2010) Seok Hyun Kim et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design

(2010) Yong Wha Moon et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis

(2010) Han Hong Lee et al.   Cancer Research and Treatment

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005

(2009) Kyu-Won Jung et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer

(2008) Edgardo Rivera et al.   CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER